Perkin-Elmer
This article was originally published in The Gray Sheet
Executive Summary
Shareholders approve recapitalization proposal that will create two new classes of common stock on May 5 to separately track the performance of the company's PE Biosystems Group (PEB) and Celera Genomics Group (CRA) businesses on the New York Stock Exchange. In conjunction with the move, Perkin-Elmer changes its name to PE Corporation, effective May 5